SCHEMBL16301290

SCHEMBL16301290

COc1ccc(C2(c3ccc(OC)cc3)C=Cc3c4c(c5cc(OC)c(-c6ccc(OC)cc6OC)cc5c3O2)-c2ccccc2C42CC(C)(C)C(C)(C)C2)cc1

nearest known ligand 0.34

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
EDNRB P24530 1/20 0.31
EDNRA P25101 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13868727 0.94 EDNRB (0.31) EDNRBEDNRA
SCHEMBL10293033 0.94 EDNRB (0.31) EDNRBEDNRA
SCHEMBL10293050 0.92
SCHEMBL10263118 0.92 EDNRB (0.33) EDNRBEDNRA
SCHEMBL16301286 0.92
SCHEMBL15452288 0.91 EDNRB (0.30) EDNRBEDNRA
SCHEMBL10261649 0.91 EDNRB (0.31) EDNRBEDNRA
SCHEMBL12424668 0.91 SLC6A3 (0.31)
SCHEMBL16301285 0.90 EDNRB (0.31) EDNRBEDNRA
SCHEMBL16301312 0.90 EDNRB (0.31) EDNRBEDNRA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8691120-B2 Chromene compound TOKUYAMA CORPORATION (JP) 2014-04-08 US disclosed
US-20120170098-A1 CHROMENE COMPOUND TOKUYAMA CORPORATION (JP) 2012-07-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120170098-A1 CHROMENE COMPOUND CRY2, CRY1, SUN2 EDNRB 3499/4885EDNRA 2966/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.